Atlas Trials

Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer Disease

Clinical trial NCT00480701 · COMPLETED

Trial details

NCT number
NCT00480701
Sponsor
Institute for Neurodegenerative Disorders
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer DiseaseParkinson Disease
Start date
2007-02-01
Primary completion
2011-10-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.